|
1
|
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
$13.7M
|
–
|
–
|
–
|
|
|
2
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$11.4M
|
-$922K
|
-52,853
|
-7%
|
|
|
3
|
Fidelity Investments
Boston,
Massachusetts
|
$8.83M
|
-$5.37M
|
-308,037
|
-37%
|
|
|
4
|
Bellevue Group
Kuesnacht,
Switzerland
|
$5.97M
|
–
|
–
|
–
|
|
|
5
|
|
$5.23M
|
-$323K
|
-18,532
|
-6%
|
|
|
6
|
|
$4.64M
|
–
|
–
|
–
|
|
|
7
|
Vanguard Group
Malvern,
Pennsylvania
|
$4.21M
|
+$372K
|
+21,347
|
+9%
|
|
|
8
|
Bank of America
Charlotte,
North Carolina
|
$4.17M
|
+$3.52M
|
+202,034
|
+398%
|
|
|
9
|
EcoR1 Capital
San Francisco,
California
|
$3.38M
|
–
|
–
|
–
|
|
|
10
|
PFM Health Sciences
San Francisco,
California
|
$2.68M
|
-$1.56M
|
-89,195
|
-35%
|
|
|
11
|
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$2.03M
|
+$2.12M
|
+121,312
|
+6,318%
|
|
|
12
|
|
$1.91M
|
+$818K
|
+46,904
|
+68%
|
|
|
13
|
Geode Capital Management
Boston,
Massachusetts
|
$1.78M
|
+$115K
|
+6,619
|
+7%
|
|
|
14
|
|
$1.76M
|
+$978K
|
+56,109
|
+112%
|
|
|
15
|
State Street
Boston,
Massachusetts
|
$1.52M
|
+$14.4K
|
+824
|
+0.9%
|
|
|
16
|
UBS Group
Zurich,
Switzerland
|
$1.43M
|
+$819K
|
+46,979
|
+118%
|
|
|
17
|
Millennium Management
New York
|
$1.24M
|
+$1.26M
|
+72,208
|
+2,354%
|
|
|
18
|
Renaissance Technologies
New York
|
$1.14M
|
+$653K
|
+37,460
|
+119%
|
|
|
19
|
Dimensional Fund Advisors
Austin,
Texas
|
$1.13M
|
-$137K
|
-7,832
|
-10%
|
|
|
20
|
Charles Schwab
San Francisco,
California
|
$629K
|
+$8.49K
|
+487
|
+1%
|
|
|
21
|
Northern Trust
Chicago,
Illinois
|
$616K
|
+$3.89K
|
+223
|
+0.6%
|
|
|
22
|
TD Asset Management
Toronto,
Ontario, Canada
|
$562K
|
-$115K
|
-6,591
|
-16%
|
|
|
23
|
Two Sigma Investments
New York
|
$523K
|
+$553K
|
+31,708
|
New
|
|
|
24
|
|
$472K
|
-$1.96M
|
-112,456
|
-80%
|
|
|
25
|
|
$467K
|
+$450K
|
+25,812
|
+1,033%
|
|
